Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

137 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
The use of granulocyte colony-stimulating factors following peripheral blood progenitor cell rescue after high-dose chemotherapy for advanced breast cancer: a prospective study.
Dazzi C, Albertazzi L, Rosti G, Maestri A, Fiorentini G, Leoni M, Tienghi A, Turci D, Ferrante P, Vertogen B, Cariello A, Latino W, Zumaglini F, Marangolo M. Dazzi C, et al. Among authors: maestri a. Tumori. 1997 Nov-Dec;83(6):900-3. doi: 10.1177/030089169708300605. Tumori. 1997. PMID: 9526580 Clinical Trial.
Negative prognostic factors and resulting clinical outcome in patients with metastatic renal cell carcinoma included in the Italian nivolumab-expanded access program.
Bracarda S, Galli L, Maruzzo M, Lo Re G, Buti S, Favaretto A, Di Costanzo F, Sacco C, Merlano M, Mucciarini C, Zafarana E, Romito S, Maestri A, Giorgio CG, Ionta MT, Turci D, De Giorgi U, Procopio G, Cortesi E, Giannarelli D, Porta C. Bracarda S, et al. Among authors: maestri a. Future Oncol. 2018 Jun;14(14):1347-1354. doi: 10.2217/fon-2017-0570. Epub 2018 May 18. Future Oncol. 2018. PMID: 29774766
Medical treatment of brain metastases from solid tumours.
Cappuzzo F, Mazzoni F, Maestri A, Di Stefano A, Calandri C, Crino L. Cappuzzo F, et al. Among authors: maestri a. Forum (Genova). 2000 Apr-Jun;10(2):137-48. Forum (Genova). 2000. PMID: 10875975 Review.
Safety and efficacy of nivolumab for metastatic renal cell carcinoma: real-world results from an expanded access programme.
De Giorgi U, Cartenì G, Giannarelli D, Basso U, Galli L, Cortesi E, Caserta C, Pignata S, Sabbatini R, Bearz A, Buti S, Lo Re G, Berruti A, Bracarda S, Cognetti F, Rastelli F, Fornarini G, Porta C, Turci D, Sternberg CN, Procopio G; Italian Nivolumab Renal Cell Cancer Early Access Program Group. De Giorgi U, et al. BJU Int. 2019 Jan;123(1):98-105. doi: 10.1111/bju.14461. Epub 2018 Jul 23. BJU Int. 2019. PMID: 29956884 Free article.
A comparison of the antiemetic efficacy and safety of intramuscular and intravenous formulations of granisetron in patients receiving moderately emetogenic chemotherapy.
Contu A, Olmeo N, Piro S, Sabbatini R, Depenni R, Silingardi V, Zaniboni A, Meriggi F, Donati D, Maestri A, et al. Contu A, et al. Among authors: maestri a. Anticancer Drugs. 1995 Oct;6(5):652-6. doi: 10.1097/00001813-199510000-00004. Anticancer Drugs. 1995. PMID: 8845475 Clinical Trial.
Phase II study of gemcitabine-cisplatin-paclitaxel triplet as induction chemotherapy in inoperable, locally-advanced non-small cell lung cancer.
Cappuzzo F, De Marinis F, Nelli F, Calandri C, Maestri A, Benedetti G, Migliorino MR, Cortesi E, Rastelli F, Martelli O, Andruccetti M, Bartolini S, Crinò L. Cappuzzo F, et al. Among authors: maestri a. Lung Cancer. 2003 Dec;42(3):355-61. doi: 10.1016/s0169-5002(03)00365-9. Lung Cancer. 2003. PMID: 14644524 Clinical Trial.
137 results